Novo Nordisk


University of Buffalo Investigators Contribute to the Global Trial Leading to the Approval of Fiasp®

Two clinical investigators from the Jacobs School of Medicine and Biomedical Sciences at the University of Buffalo (UB) participated in a successful worldwide Novo Nordisk-sponsored clinical trial, confirming that a fast-acting insulin is safe for children with...

Novo Nordisk Enters into Agreement with Bluebird Bio, a Company Currently in Litigation with Errant Gene Therapeutics

Novo Nordisk and Bluebird Bio., previously known as Genetix and purchased by Third Rock Ventures, will collaborate to develop genome editing treatments for genetic diseases, citing specifically the bleeding disease hemophilia as a target disorder, noted Jonathan...

Pin It on Pinterest